
Professor Peter Toth
CGH Medical Center and The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore (United States of America)
Membership:
FESC Member
Follow
Contributor content
Presentation
Enhanced risk stratification for hard CVD outcomes: Integrating CERT2 with coronary artery calcium assessment in the MESA cohort
Presentation
Low-density lipoprotein cholesterol goal attainment with "inclisiran first" versus usual care in patients with atherosclerotic cardiovascular disease
Presentation
Reduction in the risk of MACE with apabetalone in patients with recent acute coronary syndrome and diabetes according to NAFLD fibrosis score: exploratory analysis of the BETonMACE trial
Presentation
Final Comments and Summary.
Presentation
Welcome and Opening Remarks.
Presentation
High risk US adults with untreated hyperlipidaemia in NHANES: estimated reduction in cardiovascular events with statin treatment.
Presentation
Effect of evolocumab on lipoprotein(a) levels: results across 15 studies
Presentation
Triglycerides 150 mg/dL and above are associated with an increased risk of peripheral arterial revascularization in high-risk statin-treated patients: A real-world analysis
Presentation
Comparing Friedewald & novel calculations for estimating low-density lipoprotein cholesterol goal attainment using national health and nutrition examination survey data: implications for patient care
Presentation

